BRIDGED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS
The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts or solvates thereof, wherein all the variables are as defined herein. These compounds modulate the activity of farnesoid X receptor
-
Paragraph 1005-1006
(2019/05/15)
More Articles about upstream products of 35195-81-4